CytoMed Therapeutics Limited - (GDTC) share price
CytoMed Therapeutics Limited - (NASDAQ:GDTC) last traded at $0.86, down 2.39% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.01B and a 52-week range of $0.68 to $2.29.
| Exchange | NASDAQ |
|---|---|
| Currency | USD |
| Last price | $0.86 |
| 1-day move | -2.39% |
| 52-week range | $0.68 - $2.29 |
| Market cap | $0.01B |
| From 52-week high | -62.50% |
| Volume vs average | 0.5x |
| Falling Shares risk score | 25/100 (MODERATE) |
| Country | United States |
Frequently asked questions
Why is CytoMed Therapeutics Limited - falling today?
CytoMed Therapeutics Limited - (NASDAQ:GDTC) is down 2.39% at its latest quote and trades 62.5% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.
What is the CytoMed Therapeutics Limited - share price today?
CytoMed Therapeutics Limited - (NASDAQ:GDTC) last traded at $0.86, a -2.39% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.
What is the 52-week range of CytoMed Therapeutics Limited -?
CytoMed Therapeutics Limited -'s 52-week low is $0.68 and its 52-week high is $2.29; the shares trade 62.5% below the high.
What is the market cap of CytoMed Therapeutics Limited -?
CytoMed Therapeutics Limited - has a market capitalisation of about $0.01B at the latest price.
What are the risks of investing in CytoMed Therapeutics Limited -?
Falling Shares Intelligence rates CytoMed Therapeutics Limited - 25/100 (MODERATE) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.
Data is compiled from public exchange feeds and may be delayed. Not investment advice.
Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com